Q1 2019 Holdings
Filed 2019-05-15 | 93 holdings | $348.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $53.2M | 6,537,566 | 15.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $49.2M | 393,750 | 14.1% |
| Axogen Inc(AXGN) | COM | 05463X106 | $37.2M | 1,767,006 | 10.7% |
| Alector Inc(ALEC) | COM | 014442107 | $36.6M | 1,956,923 | 10.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $35.4M | 667,000 | 10.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $35.3M | 5,893,416 | 10.1% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $34.0M | 5,161,355 | 9.7% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $17.0M | 144,194 | 4.9% |
| Addus Homecare Corp(ADUS) | COM | 006739106 | $16.1M | 252,915 | 4.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $13.6M | 921,234 | 3.9% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $9.4M | 326,797 | 2.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $9.2M | 3,284,298 | 2.6% |
| Horizon Pharma PLC | SHS | G4617B105 | $170.8K | 6,462,634 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $144.9K | 5,227,035 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $143.5K | 8,023,600 | 0.0% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $131.5K | $116,032,000 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $100.9K | $100,000,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $90.8K | 2,617,543 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $90.7K | 3,199,789 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $76.4K | 1,608,785 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $72.9K | 3,794,783 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $64.5K | 2,005,964 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $58.5K | 1,255,174 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $57.2K | $57,791,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $54.3K | 743,439 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $51.8K | 997,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $46.0K | 386,000 | 0.0% |
| Diplomat Pharmacy Inc(DPLOEUR) | COM | 25456K101 | $41.0K | 7,049,297 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $40.6K | 506,865 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $36.2K | 579,463 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $33.6K | 1,502,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $31.1K | 364,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $29.9K | 1,702,897 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $29.6K | 1,689,000 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $28.8K | 2,043,527 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $28.7K | $65,423,000 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $28.3K | 1,158,841 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $27.4K | 439,609 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $27.3K | 1,322,834 | 0.0% |
| Dexcom Inc | NOTE 0.750% 5/1 | 252131AF4 | $26.9K | $20,000,000 | 0.0% |
| DFB Healthcare Acquistion Co | UNIT 01/30/2023 | 23291E208 | $25.4K | 2,500,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $23.7K | 1,310,259 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $23.6K | 2,355,136 | 0.0% |
| Sientra Inc | COM | 82621J105 | $23.4K | 2,730,632 | 0.0% |
| Wright MED Group N V | NOTE 2.250%11/1 | 98236JAB4 | $21.1K | $13,625,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $20.8K | 176,958 | 0.0% |
| Exact Sciences Corp | DBCV 1.000% 1/1 | 30063PAA3 | $20.5K | $15,000,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $19.3K | 493,901 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $18.6K | 650,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $18.5K | 252,200 | 0.0% |